MYP_030052
Basic Information
Unnamed
Antimicrobial
Antiviral
Antiviral Anti-HIV
Antiviral Antiviral mechanism Viral fusion inhibition Fusion inhibitor
Standard
38 amino acids
C196H311N57O62
Standard
Sequence
TTWEAWDRAIAEYAARIEALLRALQEQQEKNEAALREL
Physicochemical Analysis
4457.91 Da
4.64
-3.58
-3.79
-0.0943
-0.64
0.62
-0.15
60.58
95.53
0.0789
12490.00
12490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1976.67
-16.62
69.0
59.0
151.0
315.0
5.0
41.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0368016 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
HIV gp41 fusion inhibitor
32630.0
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Antiviral Anti-HIV
HIV-Res
0.10 μg/mL
IC50
RECORD: Rec_0371691 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor
Qualitative inhibition
RECORD: Rec_0419483 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV
LC-MS/MS
Intravenously administered to Sprague–Dawley rats, in vivo; 15120 s
Showing 3 records on this page · Page 3 of 3